Overview
This webinar is available only in Chinese.
Artificial intelligence (AI) is revolutionizing drug development at an unprecedented rate. Certara.AI leverage AI to streamline key processes, including drug discovery, clinical trial design, and regulatory submissions, enabling researchers and professionals to enhance efficiency, reduce costs, and accelerate progress while maintaining data security and integrity. As an AI-powered tool, CoAuthor dramatically boosts medical writing efficiency and shortens drug development timelines.
In this webinar, we will delve into the latest features of Certara.AI and CoAuthor, along with their practical applications in drug development. Attendees will have the opportunity to learn how AI-driven tools can simplify drug development processes, accelerate document preparation, and improve overall productivity. Additionally, experts will share real-world examples of how AI enhances data analysis, clinical trial design, medical writing, and other critical phases, demonstrating its pivotal role in advancing drug development.
Date: Tuesday, April 15, 2025
Time: 2pm – 3pm, China time
Solutions: Regulatory
Services: Regulatory Writing
Products: CoAuthor, Certara.AI
Revolutionizing Medical Writing: AI Accelerates Drug Development Efficiency
Software Solution Consultant, Certara
Ruijuan graduated from East China Normal University and is a visiting scholar at the University of Houston, USA. She is an expert in bioinformatics, with rich working experience in disease detection and drug development. Currently, she is responsible for the consulting service for drug development-related software at Certara and possesses profound knowledge and experience in utilizing Pinnacle 21 Enterprise (P21E) to ensure data compliance with CDISC standards.
